Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center

BACKGROUND: Real‐world data of the CM regimen [cyclophosphamide (CTX) plus methotrexate (MTX)] in metronomic pattern for advanced breast cancer is limited to small‐sample or retrospective studies. This study was aimed to determine the effectiveness and safety of CM regimen in treating advanced breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Qianyi, Lee, Kaping, Xu, Fei, Xia, Wen, Zheng, Qiufan, Hong, Ruoxi, Jiang, Kuikui, Zhai, Qinglian, Li, Yuan, Shi, Yanxia, Yuan, Zhongyu, Wang, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238669/
https://www.ncbi.nlm.nih.gov/pubmed/32390331
http://dx.doi.org/10.1002/cac2.12029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238669/
https://www.ncbi.nlm.nih.gov/pubmed/32390331
http://dx.doi.org/10.1002/cac2.12029

Ejemplares similares